| | Hang Seng Index | 26.400 HKD | +0.580 | +2.246% | 209.35M | 5.49B | 26.071 (+1.263%) HKD as at 2025/12/30 | | |
| | Hang Seng China Enterprises Index | 93.440 HKD | +2.180 | +2.389% | 45.85M | 4.26B | 92.157 (+1.393%) HKD as at 2025/12/30 | | |
| | Hang Seng TECH Index | 5.595 HKD | +0.205 | +3.803% | 520.89M | 2.89B | 5.464 (+2.405%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.475 HKD | +0.370 | +7.248% | 186.19M | 1.00B | 5.240 (+4.477%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.342 HKD | -0.104 | -7.192% | 496.92M | 676.85M | 1.413 (-5.038%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.758 HKD | -0.082 | -4.457% | 146.83M | 260.89M | 1.802 (-2.453%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 6.130 HKD | +0.285 | +4.876% | 34.55M | 209.21M | 5.991 (+2.324%) HKD as at 2025/12/30 | | |
| | | 10.510 HKD | +0.090 | +0.864% | 16.94M | 177.75M | 10.466 (+0.417%) HKD as at 2025/12/30 | | |
| | Hang Seng TECH Index (net total return version) | 11.980 HKD | +0.440 | +3.813% | 10.85M | 128.45M | 11.699 (+2.404%) HKD as at 2025/12/30 | | |
| | Hang Seng TECH Index | 5.685 HKD | +0.200 | +3.646% | 19.51M | 110.03M | 5.555 (+2.340%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | SK hynix Inc. | 17.140 HKD | +0.990 | +6.130% | 6.54M | 109.54M | 16.139 (+6.201%) HKD as at 2025/12/30 | | |
| | Hang Seng High Dividend 30 Index (price return version) | 19.630 HKD | +0.070 | +0.358% | 2.23M | 43.61M | 19.669 (-0.199%) HKD as at 2025/12/30 | | |
| | | 9.345 HKD | +0.140 | +1.521% | 4.39M | 40.90M | 9.263 (+0.881%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Samsung Electronics Co Ltd | 36.200 HKD | +2.700 | +8.060% | 925.60K | 32.94M | 33.185 (+9.087%) HKD as at 2025/12/30 | | |
| | London Gold Fixing Price | 20.520 HKD | +0.100 | +0.490% | 1.41M | 28.88M | 20.595 (-0.363%) HKD as at 2025/12/30 | | |
| | London Gold Fixing Price | 3,129.000 HKD | +17.000 | +0.546% | 7.30K | 22.76M | 398.810 (+0.728%) USD as at 2025/12/29 | | |
| | London Gold Fixing Price | 18.360 CNY | +0.040 | +0.218% | 1.07M | 19.72M | 18.483 (-0.664%) CNY as at 2025/12/30 | | |
| | CSI 300 Index | 53.980 HKD | +0.660 | +1.238% | 357.75K | 19.30M | 53.699 (+0.523%) HKD as at 2025/12/30 | | |
| | FTSE China A50 Index | 16.550 HKD | +0.180 | +1.100% | 688.87K | 11.40M | 16.490 (+0.367%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises Index | 3.512 HKD | +0.112 | +3.294% | 3.08M | 10.69M | 3.426 (+2.504%) HKD as at 2025/12/30 | | |
| | Hang Seng Biotech Index | 14.530 HKD | +0.180 | +1.254% | 718.40K | 10.40M | 14.515 (+0.105%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 26.880 HKD | +0.240 | +0.901% | 355.60K | 9.49M | 26.905 (-0.093%) HKD as at 2025/12/30 | | |
| | CSI 300 Index | 34.900 HKD | +0.200 | +0.576% | 215.40K | 7.48M | 34.743 (+0.452%) HKD as at 2025/12/30 | | |
| | Hang Seng High Dividend Yield Index | 30.540 HKD | +0.140 | +0.461% | 240.11K | 7.32M | 30.441 (+0.326%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index | 8.250 HKD | +0.250 | +3.125% | 742.50K | 6.10M | 8.263 (-0.156%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.224 HKD | +0.004 | +0.124% | 1.85M | 5.98M | 3.201 (+0.734%) HKD as at 2025/12/30 | | |
| | NASDAQ-100 Index | 4,814.000 HKD | +4.000 | +0.083% | 1.08K | 5.19M | 620.870 (-0.456%) USD as at 2025/12/29 | | |
| | | 10.930 HKD | +0.110 | +1.017% | 475.00K | 5.17M | 10.845 (+0.788%) HKD as at 2025/12/30 | | |
| | FTSE China A50 Index | 15.320 HKD | +0.200 | +1.323% | 333.81K | 5.10M | 15.286 (+0.221%) HKD as at 2025/12/30 | | |
| | | 8.960 HKD | +0.090 | +1.015% | 552.80K | 4.94M | 8.911 (+0.549%) HKD as at 2025/12/30 | | |